EMD Serono, USA
Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany

Newsroom

To keep up with the latest news in real-time, subscribe to our email alerts, and follow us on Twitter, Facebook and LinkedIn. If you are a reporter and have questions about the company, please contact us

Latest News

 

Feb 1, 2018

For the second year in a row, the North American businesses of Merck KGaA, Darmstadt, Germany, a leading science and technology company, have been certified for the company's outstanding employee...

Feb 1, 2018

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the US and Canada, today announced that six posters evaluating investigational Cladribine Tablets in multiple...

Jan 16, 2018

Company to present three abstracts on M7824, its investigational early phase PD-L1/TGF-β bifunctional immuno-oncology asset Noteworthy data includes encouraging preliminary expansion cohort data...

Dec 21, 2017

Not intended for UK-based media Second Breakthrough Therapy Designation for avelumab in hard-to-treat cancer Renal cell carcinoma, the most common form of kidney cancer, has a poor prognosis in...

  All Press Releases

In the News

 

No items to display.

  All In the News